Maleate salts of a quinazoline derivative useful as an antiangiogenic agent

Details for Australian Patent Application No. 2004303590 (hide)

Owner AstraZeneca AB

Inventors McCabe, James

Agent Davies Collison Cave

Pub. Number AU-B-2004303590

PCT Pub. Number WO2005/061488

Priority 0330002.7 24.12.03 GB

Filing date 18 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 30 July 2009

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Event Publications

29 June 2006 PCT application entered the National Phase

  PCT publication WO2005/061488 Priority application(s): WO2005/061488

30 July 2009 Application Accepted

  Published as AU-B-2004303590

26 November 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303592-Antharquinone compounds as anti cancer compounds

2004303587-Polymerisation using chain transfer agents